Institut Marquès presents the 1000th birth of its international embryo adoption programme. It is a baby girl called Georgina who, with 3,500 kg. of weight, was born in the town of Essex (UK) last February. Her mother decided to adopt an embryo at Institut Marquès, a clinic in Barcelona, after having performed several cycles of assisted reproduction without success in different centres. In June, an embryo that had been frozen for years was transferred; it came from the treatment of a couple who did not answer about the destination they wanted for their embryos and they were thus left under the custody of the clinic.
Kerry Andersen, Georgina's mother, is a midwife. A 45-year-old single woman who believes that this treatment has given her "the best of my life, which was the hope of being a mother. I am thrilled to think that my precious daughter is here thanks to the embryo adoption programme as I feel it is a very special way to enjoy motherhood. When I got to know this program, I did not hesitate to adopt an embryo”.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8112351-institut-marques-women-spain-adopt-embryos/
GetWellNetwork®, the health care technology company that pioneered Interactive Patient Care™, introduced today a model for enhanced patient and family engagement that mirrors the fundamentals of precision medicine. Supported by The Patient’s Platform™ — a cross-continuum suite of integrated solutions, tools and strategies — Precision Engagement™ delivers uniquely personalized care guided by a person’s ability to take an active role in their health journey.
To view the multimedia release go to:
https://www.multivu.com/players/English/8151751-getwellnetwork-precision-engagement-the-patient-platform/
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
Accurate medical transcription services ensure precise records for infectious disease care, aiding diagnosis, treatment, compliance, and communication.
The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education facility to expand their services further. These expansions are part of constant improvements that have been occurring for the last 15 years, alongside high quality service.
The area of the clinic has increased by ten-fold to approximately 1800 m2 during the years. Moreover, the oral surgery division was opened in 2015, so eight dental treatment rooms and four oral surgery rooms are now in place today. All of the surgery rooms can serve ambulatory oral surgery treatments. The ImplantCenter is unique in Hungarian private dentistry because they can implement more complex treatments in the framework of one-day oral surgery procedure. This is due to the big and fully equipped operating room opened in November 2017. As part of the service, the ImplantCenter offers one and two-bed private rooms with medical supervision to their patients after each surgery.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8274651-implantcenter-hungarian-dental-service/
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor. This new approach to treating blood cancers works by blocking BTK, a protein that helps certain cancer cells live and grow.1 IMBRUVICA is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), or adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy, or in first line in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762540-janssen-ec-approval-imbruvica-mcl-cll/
Today the Confederation of Meningitis Organisations (CoMO) is urging people all over the world to “Join Hands Against Meningitis” in an effort to reduce the global impact of the disease. The call-to-action encourages individuals, families and communities to learn the signs and symptoms of meningitis, the importance of urgent treatment of the disease, and that prevention is available through vaccination against some forms of meningitis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55808-world-meningitis-day-join-the-fight-to-stop-meningitis
Are you someone who sweats all of the time? Have you tried just about every remedy you can think of and it still isn't getting any better? If so, this article will tell you how to stop sweating naturally. It can be very embarrassing when people appear to treat you as if you are unhygienic even though you know that you have showered at least twice that day and, to top it all off, if your self-esteem wasn't already low enough; the way in which others treat you can make it even worse.
We had a great solution for your problem!!!
Please visit us on http://www.howtostopsweatingnaturally.net and http://www.howtostopsweatingnaturally.net/stop-excessive-sweating-naturally
Are you in need of a vacation? How about one with red carpet treatment and behind-the-scenes access to popular Central Florida attractions? Less than a month remains to show how you and your
My mother is almost 90 years and has a hearing loss problem. Her problem started when she was around 70 years. But, most health or physical issues start much earlier. They start from the early twenties or sooner. As you age, your various organs and physical structures start to weaken and deteriorate and become less active. The deterioration rate depends on your emotional and physical health.
Many people have an inflamed body and don’t know it. They are surprised when they develop arthritis, muscle pain, acid reflux, hiatus hernia, or gout. So how did they get to this point? All disease takes time to develop and gout is no different.
Hi, Rudy here to give you some information to get you started in eliminating your gout and acid body.
